2019
DOI: 10.1021/acsbiomaterials.9b01226
|View full text |Cite
|
Sign up to set email alerts
|

Mixed Lanthanide Oxide Nanoparticles Coated with Alginate-Polydopamine as Multifunctional Nanovehicles for Dual Modality: Targeted Imaging and Chemotherapy

Abstract: Integrating anticancer drugs and diagnostic agents in a polymer nanosystem is an emerging and promising strategy for improving cancer treatment. However, the development of multifunctional nanoparticles (NPs) for an "all-in-one" platform characterized by specific targeting, therapeutic efficiency, and imaging feedback remains an unmet clinical need. In this study, pH-responsive mixed-lanthanide-based multifunctional NPs were fabricated based on simple metal−ligand interactions for simultaneous cancer cell imag… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
11
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 64 publications
1
11
0
Order By: Relevance
“…Similarly, the high reactivity of the surface groups enable modification of the PAMAM dendrimer with different active targeting groups. Several active targeting ligands including monoclonal antibodies [16,28], peptides [29], transferrin, folic acid, and other vitamins [27,30,31] have been coupled to dendrimers to boost their cellular uptake and increase their efficiency as drug nanocarriers.…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, the high reactivity of the surface groups enable modification of the PAMAM dendrimer with different active targeting groups. Several active targeting ligands including monoclonal antibodies [16,28], peptides [29], transferrin, folic acid, and other vitamins [27,30,31] have been coupled to dendrimers to boost their cellular uptake and increase their efficiency as drug nanocarriers.…”
Section: Introductionmentioning
confidence: 99%
“…The release pattern of DOX from G4.5-DOX and that of RESV and DOX from Na-DOC-hyd-RESV+G4.5-DOX were tested in media of different pH (5.0, 6.5 and 7.4). DOX release studies from G4.5-DOX were performed based on a previously reported method [ 35 , 36 , 37 , 38 , 40 ]. Briefly, 1.0 mL G4.5-DOX solution was placed in a dialysis tube (membrane with 1 kDa MW cut-offs) and immersed in a separate vial containing 10 mL PBS at various pH (5.0, 6.5 and 7.4).…”
Section: Methodsmentioning
confidence: 99%
“…2.4.1. Doxorubicin Loading and Releasing of G4.5 PAMAM Dendrimer Doxorubicin encapsulation in G4.5 PAMAM dendrimer (G4.5-DOX) was performed based on previously reported method with some modifications [35][36][37][38]. Briefly, 10 mg G4.5 PAMAM was dissolved in 2 mL deionized water.…”
Section: Drug Loading and Releasing Studiesmentioning
confidence: 99%
“…Barium nanoparticles have been used as drug carriers and treating cancer cells [ 21 , 22 , 23 , 24 ]. Dysprosium nanoparticles have been used for targeted cancer imaging and chemotherapy [ 25 , 26 ]. Samarium nanoparticles have also been reported to enhance anti-cancer activity [ 27 ] and deliver anti-cancer drugs [ 28 ].…”
Section: Introductionmentioning
confidence: 99%